Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone 8PA3) SynExpress C-mCh-I4-K Modified CD8+ T cells (CAT#: ITS-1224-CR278)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 8PA3). We employs the pCDNA (CMV-mCherry-IL-4-KpnI) vector components and the SynExpress system of the Exons Deletion/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CCL2
Clone
8PA3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mCherry
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Deletion
Modification Domain
Exons
Carrier Type
pCDNA
Transformation Accuracy
0.92
Cell Culture
3D Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving